发明名称 |
Treatment of acute myocardial infarction (AMI) using encapsulated cells encoding and secreting GLP-1 peptides or analogs thereof |
摘要 |
<p>The present application refers to the use of cells, e.g. mesenchymal stem cells or mesenchymal stromal cells, or any further suitable cell, encoding and secreting GLP-1, a fragment or variant thereof or a fusion peptide comprising GLP-1 or a fragment or variant thereof, for the treatment of acute myocardial infarction (AMI or MI), wherein the cells, encoding and secreting GLP-1, a fragment or variant thereof or a fusion peptide comprising GLP-1 or a fragment or variant thereof, are encapsulated in a (spherical) microcapsule to prevent a response of the immune system of the patient to be treated. The present application also refers to the use of these (spherical) microcapsule(s) or of a pharmaceutical composition containing these cells or (spherical) microcapsule(s) for the treatment of acute myocardial infarction (AMI or MI).</p> |
申请公布号 |
EP2163243(A1) |
申请公布日期 |
2010.03.17 |
申请号 |
EP20080016137 |
申请日期 |
2008.09.12 |
申请人 |
BIOCOMPATIBLES UK LIMITED |
发明人 |
WALLRAPP, CHRISTINE DR.;THOENES, ERIC;LEWIS, ANDREW LENNARD;STRATFORD, PETER WILLIAM |
分类号 |
A61K9/50;A61P9/00;C12N5/00 |
主分类号 |
A61K9/50 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|